Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Diabetic Medicine ◽

10.1111/j.1464-5491.2011.03547.x ◽

2012 ◽

Vol 29 (6) ◽

pp. 716-720 ◽

Author(s):

P. D. Home ◽

L. Meneghini ◽

U. Wendisch ◽

R. E. Ratner ◽

T. Johansen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Health Status ◽

Insulin Glargine ◽

Insulin Degludec

Download Full-text

Acylated-based long-acting insulin analogues: Is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2014.10.001 ◽

2014 ◽

Vol 40 (6) ◽

pp. 483-484 ◽

Author(s):

L. Monnier ◽

C. Colette ◽

D. Owens

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Analogues ◽

Insulin Degludec ◽

Insulin Antibody ◽

Daily Insulin ◽

Acting Insulin ◽

Download Full-text

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes

Endocrine Journal ◽

10.1507/endocrj.ej16-0294 ◽

2017 ◽

Vol 64 (2) ◽

pp. 133-140 ◽

Author(s):

Tatsuhiko Urakami ◽

Yusuke Mine ◽

Masako Aoki ◽

Misako Okuno ◽

Junichi Suzuki

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Crossover Study ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Randomized Crossover Study

Download Full-text

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The United Kingdom ◽

Download Full-text

Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK

Journal of Medical Economics ◽

10.3111/13696998.2014.971160 ◽

2014 ◽

Vol 18 (1) ◽

pp. 56-68 ◽

Author(s):

M. Evans ◽

M. Wolden ◽

J. Gundgaard ◽

B. Chubb ◽

T. Christensen

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The Uk ◽

Download Full-text

Review for "Effects of Insulin Degludec and Insulin Glargine U300 on Glycemic Stability in Individuals with Type 1 Diabetes: a Multicenter, Randomized Controlled Crossover Study"

10.1111/dom.14161/v1/review3 ◽

2020 ◽

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Crossover Study ◽

Insulin Degludec ◽

Randomized Controlled

Download Full-text

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

10.1016/s0140-6736(12)60204-9 ◽

2012 ◽

Vol 379 (9825) ◽

pp. 1489-1497 ◽

Author(s):

Simon Heller ◽

John Buse ◽

Miles Fisher ◽

Satish Garg ◽

Michel Marre ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Treat To Target ◽

Phase 3 ◽

Mealtime Insulin ◽

Download Full-text

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes

Diabetology International ◽

10.1007/s13340-013-0154-7 ◽

2014 ◽

Vol 5 (1) ◽

pp. 74-77 ◽

Author(s):

Kentaro Yamada ◽

Hitomi Nakayama ◽

Shuichi Sato ◽

Yuji Tajiri ◽

Hiroh Kaku ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Crossover Study ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Randomized Crossover Study

Download Full-text

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2016.07.019 ◽

2016 ◽

Vol 120 ◽

pp. 149-155 ◽

Author(s):

Yoshiko Onda ◽

Rimei Nishimura ◽

Kiyotaka Ando ◽

Hiroshi Takahashi ◽

Daisuke Tsujino ◽

...

Keyword(s):

Type 1 Diabetes ◽

Pilot Study ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Japanese Patients ◽

Insulin Degludec

Download Full-text

Reduced Risk of Nocturnal-Confirmed Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 1 Diabetes Requiring High Doses of Basal Insulin: a Meta-analysis of 2 Randomized Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2013.08.160 ◽

2013 ◽

Vol 37 ◽

pp. S54

Author(s):

Helena W. Rodbard ◽

Yehuda Handelsman ◽

Stephen C.L. Gough ◽

Todd M. Hobbs ◽

Lars Korsholm ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Randomized Trials ◽

Meta Analysis ◽

Insulin Degludec ◽

Download Full-text

COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

Value in Health ◽

10.1016/j.jval.2016.03.1286 ◽

2016 ◽

Vol 19 (3) ◽

pp. A200-A201

Author(s):

A.D. Piedade ◽

L. Paladini ◽

J.S. Alves ◽

T.d. Gonçalves ◽

F. Griciunas

Keyword(s):

Public Health ◽

Diabetes Mellitus ◽

Health Care ◽

Type 1 Diabetes ◽

Cost Analysis ◽

Insulin Glargine ◽

Insulin Degludec ◽

Public Health Care ◽

Public Health Care System

Download Full-text